IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $170,464 | +8.3% | 3,757,997 | -2.0% | 0.02% | +13.6% |
| Q2 2023 | $157,387 | +11.9% | 3,835,867 | -2.5% | 0.02% | +4.8% |
| Q1 2023 | $140,636 | -13.3% | 3,934,951 | -8.3% | 0.02% | -19.2% |
| Q4 2022 | $162,125 | -99.9% | 4,292,431 | -10.5% | 0.03% | -25.7% |
| Q3 2022 | $212,178,000 | -61.9% | 4,797,132 | -68.1% | 0.04% | -50.0% |
| Q2 2022 | $557,375,000 | +4.9% | 15,056,046 | +4.9% | 0.07% | +29.6% |
| Q1 2022 | $531,541,000 | +39.9% | 14,350,460 | +14.9% | 0.05% | +58.8% |
| Q4 2021 | $380,079,000 | -3.5% | 12,490,280 | +6.4% | 0.03% | -8.1% |
| Q3 2021 | $393,670,000 | -19.5% | 11,737,321 | -4.3% | 0.04% | -17.8% |
| Q2 2021 | $489,005,000 | -13.5% | 12,258,827 | -2.6% | 0.04% | -21.1% |
| Q1 2021 | $565,599,000 | -23.7% | 12,580,056 | -4.1% | 0.06% | -25.0% |
| Q4 2020 | $741,520,000 | +45.6% | 13,114,967 | +22.2% | 0.08% | +28.8% |
| Q3 2020 | $509,235,000 | +0.3% | 10,732,025 | +24.6% | 0.06% | -7.8% |
| Q2 2020 | $507,726,000 | +185.4% | 8,611,362 | +128.9% | 0.06% | +128.6% |
| Q1 2020 | $177,888,000 | +57.9% | 3,762,445 | +101.8% | 0.03% | +86.7% |
| Q4 2019 | $112,631,000 | -3.6% | 1,864,436 | -4.4% | 0.02% | -11.8% |
| Q3 2019 | $116,816,000 | -8.5% | 1,949,864 | -1.8% | 0.02% | -5.6% |
| Q2 2019 | $127,600,000 | -36.3% | 1,985,367 | -19.5% | 0.02% | -37.9% |
| Q1 2019 | $200,284,000 | +222.4% | 2,467,469 | +114.7% | 0.03% | +163.6% |
| Q4 2018 | $62,122,000 | +10.0% | 1,149,124 | +5.0% | 0.01% | +37.5% |
| Q3 2018 | $56,456,000 | +12.7% | 1,094,536 | -8.9% | 0.01% | 0.0% |
| Q2 2018 | $50,072,000 | -15.4% | 1,201,633 | -10.5% | 0.01% | -11.1% |
| Q1 2018 | $59,152,000 | -15.3% | 1,341,932 | -3.4% | 0.01% | -18.2% |
| Q4 2017 | $69,845,000 | +22.6% | 1,388,578 | +23.5% | 0.01% | +10.0% |
| Q3 2017 | $56,982,000 | -1.5% | 1,123,900 | -1.2% | 0.01% | 0.0% |
| Q2 2017 | $57,850,000 | -23.2% | 1,137,221 | -39.3% | 0.01% | -28.6% |
| Q1 2017 | $75,333,000 | -17.1% | 1,873,959 | -1.4% | 0.01% | -22.2% |
| Q4 2016 | $90,906,000 | +140.2% | 1,900,605 | +84.0% | 0.02% | +125.0% |
| Q3 2016 | $37,853,000 | +21.2% | 1,033,100 | -22.9% | 0.01% | +14.3% |
| Q2 2016 | $31,223,000 | -41.3% | 1,340,638 | +2.0% | 0.01% | -36.4% |
| Q1 2016 | $53,226,000 | -38.6% | 1,314,228 | -6.2% | 0.01% | -38.9% |
| Q4 2015 | $86,732,000 | – | 1,400,487 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |